Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatments & Surgery
Share your love
FDA approvals in 2025: What changed and why it matters for ophthalmologists | Ophthalmology Times
Editor’s Note: This content was generated with the assistance of AI. From first-in-class pharmacologic therapies to next-generation retinal durability strategies and less invasive surgical platforms, 2025 emerged as a pivotal year for the ophthalmic pipeline. Over the past 12 months,…
Q&A: What changed in residency education in 2025? Perspectives from training directors | Ophthalmology Times
Residency programs are adapting to evolving training requirements, new technologies, and changing trainee needs to better prepare future ophthalmologists. (Image credit: AdobeStock/WavebreakMediaMicro) Ophthalmology residency training is constantly evolving, and 2025 marked a year of notable developments that are shaping how…
Surgeon reflection: What patient case stayed with you in 2025? | Ophthalmology Times
Neda Shamie reflects on a 2025 case that reminded her how trust, patience, and communication are as critical as any surgical technique. (Image credit: AdobeStock/LIGHTFIELD STUDIOS) As the year draws to a close, many clinicians are taking stock of the…
Molecular insights and clinical experience: Extending anti-VEGF durability | Ophthalmology Times
(Image Credit: AdobeStock) A recent Ophthalmology Times Case-Based Roundtable focused on extended anti-VEGF treatment durability. Peter K. Kaiser, MD, the Chaney Family Endowed Chair in Ophthalmology Research and professor of ophthalmology at the Cleveland Clinic Lerner College of Medicine in…
Glaucoma 2026: Which emerging technologies will change practice? | Ophthalmology Times
In this latest EyePod podcast episode, Joel Schuman, MD, of Wills Eye Hospital in Philadelphia, sits down with Sheryl Stevenson, executive editor with the Eye Care Network, to discuss emerging technologies that may influence glaucoma practice as clinicians look to…
Customized Clarity: Navigating IOL Options for Optimal Patient Care | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Tanner Ferguson, MD, and Taj Nasser, MD, FWCRS, discuss the management of astigmatism at the time of cataract surgery,…
Key Clinical Takeaways From Case-Based Discussions on Advanced IOL Selection | Ophthalmology Times
This concluding segment synthesizes the most important lessons attendees gained from reviewing three diverse cataract cases. For case one, the primary takeaway was the importance of anchoring IOL selection to patient identity, lifestyle, and expectations, with the enVista Envy lens…
IOL Selection and Expectation Management in a Hyperopic Patient With Astigmatism Considering Advanced Lenses | Ophthalmology Times
This final case discussed a 58-year-old hyperopic male with significant astigmatism and visually limiting cataracts who initially presented seeking LASIK but was determined to be a poor refractive surgery candidate. The panel reviewed corneal topography demonstrating oblique astigmatism and low…
IOL Selection Using a Light Adjustable Lens in a Post-LASIK Painter With Color Sensitivity | Ophthalmology Times
This case focused on a 70-year-old female painter with declining near vision, a history of myopic LASIK, and strong preferences for spectacle independence and accurate color perception. Given her profession, the group discussed how artists and photographers may be particularly…
Advanced IOL Selection in a Low Night-Driving Patient With Bilateral Cataracts | Ophthalmology Times
This segment reviews a case-based roundtable discussion focused on advanced intraocular lens (IOL) selection in cataract surgery, highlighting the importance of patient-centered decision-making. The case involved a 69-year-old retired pastor engaged in foreign mission work who presented with bilateral cataracts,…